Key result
A single-center case series presented 11 consecutive patients treated for primary angiosarcoma of the breast between 2000 and 2015.
Case Report (n=11)
No
This case series describes the clinical experience of treating 11 patients with primary angiosarcoma of the breast, a rare malignancy with an unfavorable prognosis.
Answers are grounded in this paper and cite their sources.
Offers limited experience in rare breast angiosarcoma; hypothesis-generating and should not change practice.
Angiosarcomas of the breast are rare parenchymal malignancies of the chest wall. Surgery is the main treatment modality with chemotherapy and radiotherapy used in case of recurrence. With generally unfavourable prognosis and lack of clear treatment guidelines due to its rarity and scarcity of available data, angiosarcoma of the breast is a challenging clinical situation for both oncologist and patient. We present here the results of a series of 11 consecutive primary angiosarcoma cases treated at our institute between 2000 and 2015.
No takes yet. Share an insight, caveat, or question.
Kunkiel et al. (2018) conducted a case report in Primary angiosarcoma of the breast (n=11). A single-center case series presented 11 consecutive patients treated for primary angiosarcoma of the breast between 2000 and 2015.
Synapse has enriched 10 related papers. Consider them for comparative context: